Angiotensin Receptor Neprilysin Inhibition (ARNI) Following Acute Mycardial InfarctionPrimary Results of the PARADISE-MI Trial:"The Back Story"Marc Pfeffer, MD, PhDDistinguished Dzau Professor of MedicineMay 24, 2021